Residual Oil Fly Ash Increases the Susceptibility to Infection and Severely Damages the Lungs After Pulmonary Challenge with a Bacterial Pathogen
Public Domain
-
2002/11/01
-
Details
-
Personal Author:
-
Description:Inhalation of residual oil fly ash (ROFA), a component of ambient particulate matter, has been shown to increase pulmonary morbidity and impair lung defense mechanisms in exposed workers. Our objective was to evaluate the effect of ROFA preexposure on lung defense and injury after pulmonary challenge with a bacterial pathogen. Male Sprague-Dawley rats were dosed intratracheally at day 0 with saline (control) or ROFA (0.2 or 1 mg/100 g body weight). Three days later, a low (5 x 10(3)) or high (5 x 10(5)) dose of Listeria monocytogenes was instilled intratracheally into the ROFA- and saline-treated rats. Bronchoalveolar lavage was performed on the right lungs at days 6, 8, and 10. The recovered cells were differentiated, and chemiluminescence (CL) and nitric oxide (NO) production, two indices of alveolar macrophage (AM) function, were measured. At the same time points, the left lung and spleen were removed, homogenized, and cultured, and colony-forming units were counted after an overnight incubation. Exposure to ROFA and the high dose of L. monocytogenes led to marked lung injury and inflammation as well as to an increase in mortality, compared with rats treated with saline and the high dose of L. monocytogenes. Preexposure to ROFA significantly enhanced injury and delayed the pulmonary clearance of L. monocytogenes at both bacterial doses when compared to the saline-treated control rats. ROFA had no effect on AM CL but caused a significant suppression of AM NO production, as compared to the saline control rats. We have demonstrated that acute exposure to ROFA slowed the pulmonary clearance of L. monocytogenes. The suppression in AM NO production by ROFA pretreatment likely plays an important role. These results suggest that pulmonary exposure to ROFA may alter AM function and lead to increased susceptibility to lung infection in exposed populations. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1096-6080
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:110-119
-
Volume:70
-
Issue:1
-
NIOSHTIC Number:nn:20022197
-
Citation:Toxicol Sci 2002 Nov; 70(1):110-119
-
Contact Point Address:Robert W. Clarke, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505
-
Email:jga6@cdc.gov
-
Federal Fiscal Year:2003
-
NORA Priority Area:
-
Peer Reviewed:True
-
Source Full Name:Toxicological Sciences
-
Collection(s):
-
Main Document Checksum:urn:sha-512:b09330d5771c2386bef818372bd16d20a372614311f0ab8f127ded1754286eddd425e2b9bdbf3850adfd6098cf6f7de27392078e9961c61e905e97d2ea18d907
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like